Literature DB >> 11139222

Correlation between enzyme-linked immunosorbent assay and immunofluorescence assay with lytic antigens for detection of antibodies to human herpesvirus 8.

S Topino1, L Vincenzi, I Mezzaroma, E Nicastri, M Andreoni, M C Sirianni.   

Abstract

The purpose of this study was to evaluate, in Kaposi's sarcoma patients, the correlation between antibody titers to the lytic antigens of human herpesvirus 8, as assessed by immunofluorescence assay, and values obtained by an enzyme immunoassay. The methods showed a stringent correlation, r = 0.625 (P<0.001).

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11139222      PMCID： PMC96037          DOI： 10.1128/CDLI.8.1.203-205.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  19 in total

1.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Use of epidemiologically well-defined subjects and existing immunofluorescence assays to calibrate a new enzyme immunoassay for human herpesvirus 8 antibodies.

Authors:  J N Martin; Z Amad; C Cossen; P K Lam; D H Kedes; K A Page-Shafer; D H Osmond; B Forghani
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease.

Authors:  N Dupin; I Gorin; J Deleuze; H Agut; J M Huraux; J P Escande
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

4.  Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee.

Authors:  S E Krown; C Metroka; J C Wernz
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

5.  Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma.

Authors:  C Boshoff; D Whitby; T Hatziioannou; C Fisher; J van der Walt; A Hatzakis; R Weiss; T Schulz
Journal:  Lancet       Date:  1995-04-22       Impact factor: 79.321

6.  High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission.

Authors:  M Andreoni; G El-Sawaf; G Rezza; B Ensoli; E Nicastri; L Ventura; L Ercoli; L Sarmati; G Rocchi
Journal:  J Natl Cancer Inst       Date:  1999-03-03       Impact factor: 13.506

7.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

8.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.

Authors:  Y Chang; E Cesarman; M S Pessin; F Lee; J Culpepper; D M Knowles; P S Moore
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

9.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection.

Authors:  G Miller; M O Rigsby; L Heston; E Grogan; R Sun; C Metroka; J A Levy; S J Gao; Y Chang; P Moore
Journal:  N Engl J Med       Date:  1996-05-16       Impact factor: 91.245

10.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.

Authors:  E Cesarman; P S Moore; P H Rao; G Inghirami; D M Knowles; Y Chang
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.